Created at Source Raw Value Validated value
Nov. 16, 2021, 6:30 p.m. usa

pregnancy, breastfeeding mothers, and women of childbearing age who are unable to use adequate contraception, which includes: intrauterine devices (iud), contraceptive implants, or tubal sterilization hormone method with a barrier method two barrier methods if a partner's vasectomy is the chosen method of contraception, a hormone or barrier method must also be used in conjunction history of severe hematologic or neuromuscular disorder co-administration of cypa3a4 and p-glycoprotein transport inhibitor severe renal impairment with concomitant hepatic impairment concurrent use of colchicine and strong or p-glycoprotein inhibitor with renal or hepatic impairment

pregnancy, breastfeeding mothers, and women of childbearing age who are unable to use adequate contraception, which includes: intrauterine devices (iud), contraceptive implants, or tubal sterilization hormone method with a barrier method two barrier methods if a partner's vasectomy is the chosen method of contraception, a hormone or barrier method must also be used in conjunction history of severe hematologic or neuromuscular disorder co-administration of cypa3a4 and p-glycoprotein transport inhibitor severe renal impairment with concomitant hepatic impairment concurrent use of colchicine and strong or p-glycoprotein inhibitor with renal or hepatic impairment

Oct. 26, 2020, 11:31 p.m. usa

1. pregnancy, breastfeeding mothers, and women of childbearing age who are unable to use adequate contraception, which includes: 1. intrauterine devices (iud), contraceptive implants, or tubal sterilization 2. hormone method with a barrier method 3. two barrier methods 4. if a partner's vasectomy is the chosen method of contraception, a hormone or barrier method must also be used in conjunction 2. history of severe hematologic or neuromuscular disorder 3. co-administration of cypa3a4 and p-glycoprotein transport inhibitor 4. severe renal impairment with concomitant hepatic impairment 5. concurrent use of colchicine and strong or p-glycoprotein inhibitor with renal or hepatic impairment

1. pregnancy, breastfeeding mothers, and women of childbearing age who are unable to use adequate contraception, which includes: 1. intrauterine devices (iud), contraceptive implants, or tubal sterilization 2. hormone method with a barrier method 3. two barrier methods 4. if a partner's vasectomy is the chosen method of contraception, a hormone or barrier method must also be used in conjunction 2. history of severe hematologic or neuromuscular disorder 3. co-administration of cypa3a4 and p-glycoprotein transport inhibitor 4. severe renal impairment with concomitant hepatic impairment 5. concurrent use of colchicine and strong or p-glycoprotein inhibitor with renal or hepatic impairment